A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1992
12/10/1992	CA2110062A1 2-phenylbenzo[b]furans, processes for their manufacture and pharmaceutical preparations containing them
12/10/1992	CA2110040A1 Compositions and delivery systems for transdermal administration of neutral oligomers
12/10/1992	CA2109707A1 Vegetal coumpound extraction process
12/10/1992	CA2109611A1 Phospholipids
12/10/1992	CA2109579A1 Eukaryotic expression vectors with regulation of rna processing
12/10/1992	CA2088759A1 Biodegradable particulate carrier and generation process therefor
12/10/1992	CA2088582A1 Anti-diabetes mellitus
12/09/1992	EP0517573A1 Pharmaceutical compositions for the treatment of airway disorders
12/09/1992	EP0517565A2 Process for the preparation of microspheres containing biologically active components
12/09/1992	EP0517484A2 Fermentation analogs of virginiamycin M1
12/09/1992	EP0517425A1 Fatty acids for the reduction of urinary calcium excretion and the treatment of osteoporosis
12/09/1992	EP0517412A1 Pharmaceutical formulations of a benzodiazepine
12/09/1992	EP0517394A1 A prophylactic/therapeutic composition for swine pleuropneumonia
12/09/1992	EP0517357A1 Angiotensin II antagonists incorporating a substituted indole or dihydroindole
12/09/1992	EP0517347A1 New combinations for the treatment of Parkinsons disease, containing NMDA-antagonists
12/09/1992	EP0517274A1 Pharmaceutical enema
12/09/1992	EP0517225A1 Aminopyrrolidine platinum compounds, a process for preparing them and pharmaceutical compositions containing them
12/09/1992	EP0517221A1 [(Arylalkylpiperidine-4-yl)methyl]-2-alpha,3,4,5-tetrahydro-1(2H)-acenaphthylene-1-ones and related compounds, a process for their preparation and their use as medicaments
12/09/1992	EP0517160A1 Extended-release ophthalmic preparations
12/09/1992	EP0517145A1 Crystalline oxathiolane derivatives
12/09/1992	EP0517125A1 Use of propionyl L-carnitine for regaining muscle tone in immobilised patients
12/09/1992	EP0517103A1 Piperidine derivatives, a process for the preparation thereof and the use thereof
12/09/1992	EP0517065A1 Tetracyclic beta-lactam antibiotics and process for their preparation
12/09/1992	EP0517047A1 Unsaturated 17beta-substituted 3-carboxy steroids
12/09/1992	EP0517041A1 New Cephem Compounds
12/09/1992	EP0516980A1 Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
12/09/1992	EP0516978A1 Enantiomers of substituted (aminophenyl)-heteroarylethylamines, a method for their preparation, and pharmaceutical compositions containing these compounds
12/09/1992	EP0516941A1 Pyrazolopyridine compounds and processes for preparation thereof
12/09/1992	EP0516914A2 Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
12/09/1992	EP0516896A1 Chlortetracycline hydrochloride for use as antiprotozoary preparation for cats and dogs
12/09/1992	EP0516811A1 Euthanasia compositions.
12/09/1992	EP0516795A1 Use of quisqualate-receptor antagonists for treating parkinson's disease
12/09/1992	EP0516792A1 Heparin derivatives
12/09/1992	EP0516777A1 Brain resuscitation device and method
12/09/1992	EP0516748A1 N,n'-disubstituted guanidines and their use as excitatory amino acid antagonists
12/09/1992	EP0516747A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO $g(b)-LACTAM ANTIBIOTICS
12/09/1992	EP0516685A1 Artificial tears
12/09/1992	EP0516669A1 Compositions containing green porphyrins to destroy malignant cells in mononuclear cell populations
12/09/1992	EP0516658A1 Benzopyrans having pharmacological activity
12/09/1992	EP0413783A4 Thickening agents for aqueous systems
12/09/1992	EP0310647B1 Quinoline carboxylic acid boric acid anhydrides and process for the preparation thereof
12/09/1992	EP0190233B1 New carbacyclines, preparation thereof and drug containing them
12/09/1992	CN1066849A Process for preparing tricyclotriazolo derivatives and their use
12/09/1992	CN1066848A Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents
12/09/1992	CN1066847A Angiotensin ii receptor blocking 2,3,6 substituted quinazolinones
12/09/1992	CN1066844A Azole derivate, manufacturing method and application thereof
12/09/1992	CN1066781A Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta-adrenergic antagonist
12/09/1992	CN1066779A Antibacterial mild liquid surfactant skin cleanser
12/09/1992	CN1019397B Process for bisphosphonic acid derivatives
12/09/1992	CN1019394B Process for the preparation of triazolopyrimidine derivatives
12/09/1992	CN1019393B Substituted n-((4-piperidingl) alkyl) bicyclic condensed oxazol and thiazolaminer
12/09/1992	CN1019391B Process for diastereoisomeric tetradrydropyrideo (2,3-d) pyrimidine derivatives
12/09/1992	CN1019390B Glutarimide antianxiety and artihypertensive agents
12/09/1992	CN1019388B Process for preparing n-alkylsulfurylanilline derivatives
12/08/1992	WO1992021325A1 Oral composition based on an antibiotic material and clay
12/08/1992	US5169976 N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents
12/08/1992	US5169967 Aluminum magnesium hydroxy fatty acid compounds and thermostable lipogels including same
12/08/1992	US5169947 Therapy for obesity, depression
12/08/1992	US5169946 Reacting 3-hydroxy-2,3-dihydro-5- 2-dimethyl-amino)ethyl!-2-(p-methoxyphenyl)-1,5 -benzothiazepine-4(5H)-one with acetyl chloride in acetic acid; one step
12/08/1992	US5169868 Antidepressants, enzyme inhibitors; alleviating parkinsonism, alzheimer's disease
12/08/1992	US5169867 Hydroxylamine compounds
12/08/1992	US5169865 Bioactive, amphiphilic conformation of hormones, neurotransmitters, calcium channel blockers by binding with calcium and magnesium ions
12/08/1992	US5169864 Sterile aqueous formulation of histamine H2 antagonist for antiulcer; storage stability
12/08/1992	US5169863 Hypersphyxia-causing methods
12/08/1992	US5169860 Antitumor compositions and methods of treatment
12/08/1992	US5169859 Thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same
12/08/1992	US5169858 Anti-tumor compositions containing the reactive product of benzaldehyde or salicylaldehyde with penicillamine and method of use thereof
12/08/1992	US5169856 Cholinesterase antagonists
12/08/1992	US5169855 Piperidine ether derivatives as psychotropic drugs or plant fungicides
12/08/1992	US5169854 N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity
12/08/1992	US5169852 Anorexigenic agents
12/08/1992	US5169849 Contains dihydroergotamine which depresses ciliary function and xanthine which increases it
12/08/1992	US5169847 Aqueous solutions of piroxicam, sodium glycinecarboxylate, additives, for eye drops
12/08/1992	US5169845 Piperazine derivatives
12/08/1992	US5169842 Oligophosphates with an antiviral action
12/08/1992	US5169840 Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
12/08/1992	US5169839 Pesticides for animals and plants
12/08/1992	US5169838 Benzopyranone-β-D-thioxylosides and their use in therapy
12/08/1992	US5169769 Method of hydroxylating substituted 3-aminopyridinones using mammalian tissue
12/08/1992	US5169765 Method for stimulating production of bone marrow cell growth factors using dithiocarbamates
12/08/1992	US5169640 Pharmaceutical compositions
12/08/1992	US5169639 Controlled release verapamil tablets
12/08/1992	US5169634 Pharmaceutical dosage form for the medication of fish
12/08/1992	US5169633 Mixture with a wax and(or) cellulose
12/08/1992	CA2088983A1 Therapeutic composition for gastrointestinal system inflammations
12/08/1992	CA2070714A1 ¬(arylalkylpiperidin-4-yl)methyl\|-2a,3,4,5-tetrahydro-1(2h) -acenaphthylen-1-ones and related compounds (case hoe 91/s 013/hr-1223)
12/08/1992	CA2070616A1 Cephem compounds
12/08/1992	CA2059701A1 Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
12/08/1992	CA1311243C PHARMACEUTICAL COMPOSITIONS CONTAINING .alpha.-HALOGENATED DICARBOXYLIC ACIDS
12/08/1992	CA1311242C Pesticidal method using n-phenylpyrazoles
12/08/1992	CA1311239C Porphyrin derivatives, and their production and use
12/08/1992	CA1311201C Desazapurine-nucleoside derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof fornucleic acid sequencing and as antiviral agents
12/06/1992	WO1992021690A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same
12/06/1992	WO1992021679A1 NEW HETERO-ARYLOXY-β-CARBOLINES, THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
12/06/1992	WO1992021330A1 Particulate vector having selective tropism, method of preparation and pharmaceutical composition
12/06/1992	CA2088910A1 Particulate vector with selective tropism, process for the preparation thereof and pharmaceutical composition
12/06/1992	CA2088787A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same
12/06/1992	CA2087098A1 Hetero-aryloxy-.beta.-carbolines, their preparation and their use in medicamens
12/06/1992	CA2070526A1 Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and pharmaceutical compositions containing them
12/06/1992	CA2070508A1 Aminopyrrolidine platinum compounds and process for their production

1 ... 7228 7229 7230 7231 7232 7233 7234 7235 7236 7237 7238 7239 7240 7241 7242 7243 7244 7245 7246 7247 7248 ... 7860